Paris, Ile-De-France, France
Akpéli Nordor is a French pharmacist and biotechnologist currently completing a research fellowship at Institut Curie, a leading European comprehensive cancer center in Paris.
His work focuses on deciphering molecular circuitries shared by cancer and placental cells. Akpéli was also a visiting research scholar at Massachusetts General Hospital and Harvard Medical School where he trained in computational biology for the analysis of high-throughput epigenomic and genomic datasets (from 2014 to 2015). Thus, he hopes to contribute to improvements in the scientific understanding and medical management of aggressive cancers as well as pregnancy pathologies.
Beside his research activities, Akpéli actively promotes science and technology entrepreneurship as part of Hello Tomorrow, a non-profit organization catalyzing the creation of startups disrupting traditional industries thanks to innovative technologies. He has served as secretary and head of conference since its inception.
Akpéli Nordor holds a Doctor of Pharmacy degree and a Master of Science in ‘Bioengineering for Biotherapies’ from Université Paris Descartes and ParisTech, as well as a PhD in 'Interdisciplinary Biology' from the Center for Research and Interdisciplinarity of Paris (class 2013-2016).